B. Wachall

Imidazole substituted biphenyls: a new class of highly potent and in vivo active inhibitors of P450 17 as potential therapeutics for treatment of prostate cancer.

R. Hartmann, Y. Zhuang, B. Wachall, 1999, Bioorganic & medicinal chemistry.

Inhibition of CYP 17, a New Strategy for the Treatment of Prostate Cancer

R. Hartmann, Y. Zhuang, S. Haidar, 2002 .

Novel imidazolyl and triazolyl substituted biphenyl compounds: synthesis and evaluation as nonsteroidal inhibitors of human 17alpha-hydroxylase-C17, 20-lyase (P450 17).

R. Hartmann, Y. Zhuang, B. Wachall, 2000, Bioorganic & medicinal chemistry.

Inhibition of CYP 17, a new strategy for the treatment of prostate cancer.

R. Hartmann, Y. Zhuang, S. Haidar, 2002, Archiv der Pharmazie.

Inhibition of CYP 17, a New Strategy for the Treatment of Prostate Cancer

R. Hartmann, S. Haidar, C. Klein, 2002, Archiv der Pharmazie.